Brief: Aadi Bioscience Announces Financial Results For The Second Quarter Of 2022

Whitehawk Therapeutics

10/08/2022 13:38

Aug 10 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE SECOND
QUARTER OF 2022 AND PROVIDES CORPORATE UPDATE
    * Q2 REVENUE $3.4 MILLION
    * CASH AND CASH EQUIVALENTS ON JUNE 30, 2022 WERE $118.7
MILLION,
COMPARED TO $149.0 MILLION AS OF DECEMBER 31, 2021
    * QTRLY LOSS PER SHARE $0.87
    * FYARRO® (NAB-SIROLIMUS) NET PRODUCT SALES REACHED $3.4
MILLION
FOR Q2 OF 2022

Source text for Eikon:  ID:nPn1yYD4Xa 
Further company coverage:  AADI.O 

 ((reuters.briefs@thomsonreuters.com;))